Some Emory patients with COVID-19 are part of a clinical trial of an antiviral drug that has reportedly proved effective among patients in Chicago who have severe illness. The Emory trial of remdesivir is part of a National Institutes of Health study that’s separate from the Chicago drug trial. There’s no FDA-approved treatment for COVID-19 … Continue reading Emory patients part of drug trial for potential COVID-19 treatment